Project Grant HT9425261E072
- This $997,008 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) supports a 3-year research project by the Northern California Institute for Research and Education, Inc. (NCIRE) to investigate risk and resilience factors for Alzheimer's disease and related dementias (ADRD) among American Indian and Alaskan Native veterans. The research aims to inform prevention strategies for this population. NCIRE is a...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded Northern California Institute For Research And Education, Inc. (NCIRE) a Project Grant totaling $3,051,639 under the Military Medical Research and Development program (CFDA 12.420) to conduct research on improving delivery of germline testing in veterans with advanced prostate cancer. The four-year project, which commenced September 1, 2025 and concludes August 31, 2029, will be performed at NCIRE's San Francisco,...
- Federal Grant Award Summary Northern California Institute For Research And Education, Inc. (NCIRE) received a $2.95 million Project Grant from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) awarded September 1, 2025. The grant supports a four-year research initiative examining Suvorexant, an orexin-targeting pharmaceutical agent, as an augmentation therapy to exposure therapy for veterans with post-traumatic stress disorder (PTSD) and comorbid...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded The Regents of the University of California, San Francisco a $999,999 Project Grant on September 28, 2025, under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Uncovering the Relationship Between Myelin and Synapse Dynamics in Multiple Sclerosis." The three-year project, scheduled for completion on September 27, 2028, will be performed at UCSF's San Francisco location....
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded a $993,283 Project Grant to The Regents of the University of California, San Francisco under the Military Medical Research and Development program (CFDA 12.420) for the period September 1, 2025 through August 31, 2027. The award supports research into the proteomic determinants and components of progression in multiple sclerosis. This research initiative aligns with the DHA's mission to transform healthcare for service members...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded the University of California Irvine a $747,092 Project Grant effective September 1, 2026, through August 31, 2029, under the Military Medical Research and Development program (CFDA 12.420). The project, titled "Immune Checkpoint Inhibition-Related Cognitive Impairments: Mechanisms and Mitigation," supports basic and applied biomedical research investigating cognitive side effects associated with immunotherapy...
- This federal Project Grant award for $1,607,403.00, provided by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420), supports a longitudinal study on monitoring cognitive changes in older veterans using telehealth-based computerized neuropsychological assessments. The award was granted to the East Bay Institute for Research & Education Inc., a non-profit organization in Mather, California, to conduct this 3-year research project from March 1,...
- Federal Grant Award Summary The University of California, San Francisco (UCSF) received a $999,999 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025, through July 31, 2028. This award supports the development and validation of cell-free deoxyribonucleic acid (DNA) epigenetic biomarkers for multiple sclerosis, a three-year research initiative conducted at UCSF's San Francisco facility. The project...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Regents of the University of California, San Francisco a $1.4 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective July 1, 2026, through July 31, 2029. The award supports investigator-initiated research into the metabolic mechanisms of resistance to mutant isocitrate dehydrogenase (IDH) inhibition in gliomas. This three-year research initiative will be conducted at...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded the University of California, Davis a $1.7M Project Grant under the Military Medical Research and Development program (CFDA 12.420) for a three-year research initiative running September 1, 2026, through August 31, 2029. The grant supports a novel therapeutic approach to address chemotherapy-induced peripheral neuropathy (CIPN) in prostate cancer patients by targeting soluble epoxide hydrolase (SEH) as a treatment mechanism....
The Defense Health Agency awarded Northern California Institute For Research And Education, Inc. (NCIRE) a $998,633 Project Grant under the Military Medical Research and Development program (CFDA 12.420) for a three-year period (September 1, 2026 through August 31, 2029). The project, titled "Midlife Risk Factors and Risk Score Development for AD/ADRD Among Male and Female Veterans," supports investigator-initiated biomedical research aimed at identifying and quantifying midlife risk factors associated with Alzheimer's disease and Alzheimer's disease-related dementias (AD/ADRD) with a focus on gender-specific outcomes in the veteran population. This research aligns with the program's mandate to advance medical solutions addressing Service Member and veteran health outcomes through basic, applied, and advanced biomedical research. NCIRE will conduct this hypothesis-driven clinical research leveraging its institutional capabilities in longitudinal cohort research, biomarker development and validation, and translational medical science in chronic disease and aging. The organization operates as a non-profit research entity with deep affiliation to the San Francisco Veterans Affairs Health Care System and University of California, San Francisco, positioning it to execute veteran-focused research with specialized clinical trial design and execution expertise. The award represents the organization's continued engagement with the Defense Health Agency as a prime recipient of federal research grants focused on veteran population health outcomes.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $998.6k | 4/15/26 |